Health Care & Life Sciences » Biotechnology | 22nd Century Group Inc.

22nd Century Group Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
5,830.60
6,402.70
3,760.30
13,468.20
62,635.00
56,353.90
Total Accounts Receivable
49.50
46.10
51.20
41.00
957.10
871.30
Inventories
1,406.30
2,064.80
2,706.30
3,092.70
3,282.50
3,043.90
Other Current Assets
457.70
2,193.30
710.10
195.60
746.80
928.40
Total Current Assets
7,744.10
10,706.80
7,227.90
16,797.40
67,621.50
61,197.50
Net Property, Plant & Equipment
2,997.80
2,850.60
2,555.80
2,434.70
3,316.00
3,260.70
Total Investments and Advances
-
1,318.30
1,222.70
1,020.30
1,366.50
3,092.40
Intangible Assets
1,544.90
4,875.80
5,162.10
5,187.90
5,233.40
7,549.50
Other Assets
-
2,202.00
2,202.00
2,202.00
2,202.00
2,202
Total Assets
12,286.70
21,953.50
18,370.50
27,642.40
79,739.40
77,302.10
ST Debt & Current Portion LT Debt
174.90
495.40
308.60
307.90
-
Accounts Payable
54.70
884.40
1,283.30
1,340.20
2,080.70
Other Current Liabilities
754.70
1,293.60
1,644.20
1,601.20
2,232.50
Total Current Liabilities
984.30
2,673.40
3,236.10
3,249.30
4,313.20
Long-Term Debt
-
605.20
307.90
-
-
Other Liabilities
3,779.50
3,455.20
3,098.00
58.70
-
Total Liabilities
4,763.90
6,733.80
6,642.00
3,308.00
4,313.20
Common Equity (Total)
7,522.90
15,219.70
11,728.50
24,334.40
75,426.20
Total Shareholders' Equity
7,522.90
15,219.70
11,728.50
24,334.40
75,426.20
Total Equity
7,522.90
15,219.70
11,728.50
24,334.40
75,426.20
Liabilities & Shareholders' Equity
12,286.70
21,953.50
18,370.50
27,642.40
79,739.40

About 22nd Century Group

View Profile
Address
8560 Main Street
Clarence New York 14221
United States
Employees -
Website http://www.xxiicentury.com
Updated 07/08/2019
22nd Century Group, Inc. is a plant biotechnology company, which engages in the development of technology that will allow to increase or decrease the level of nicotine and nicotinic alkaloids in tobacco plants and levels of cannabinoids in cannabis plants through genetic engineering and plant breeding. Its products include X-22, modified risk cigarettes, spectrum government research cigarettes, magic 0 and magic 2, moonlight, red sun, variable nicotine-level research cigarettes, and verfola. The company was founded on January 25, 2011 and is headquartered in Clarence, NY.